[Magnetic resonance imaging of hypertrophic cardiomyopathy : evaluation of diastolic function]

F Schwarz1, F Schwab, B M Beckmann

  • 1Institut für Klinische Radiologie, Klinikum der Ludwig-Maximilians-Universität München, Campus Grosshadern, Deutschland. Florian.Schwarz@med.uni-muenchen.de

Der Radiologe
|January 23, 2013
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) diagnosis relies on imaging. This study compared cardiac function and wall thickness in patients with and without diastolic dysfunction, crucial for assessing HCM progression.

Area of Science:

  • Cardiology
  • Medical Imaging

Context:

  • Hypertrophic cardiomyopathy (HCM) affects ~0.2% of the population, often presenting asymptomatically or with non-specific symptoms.
  • Accurate diagnosis and clinical course assessment of HCM are vital, with myocardial hypertrophy (ventricular wall thickness ≥ 15 mm) being the definitive finding.
  • Echocardiography serves as a screening tool, while cardiac magnetic resonance imaging (MRI) provides comprehensive analysis of HCM, including hypertrophy extent, cardiac function, outflow tract obstruction, and mitral valve dynamics.

Purpose:

  • To compare systolic functional parameters and end-systolic/diastolic wall thickness in patients with and without diastolic dysfunction within the context of HCM.
  • To highlight the role of advanced imaging, particularly MRI, in evaluating HCM complexity.

Summary:

  • This study investigated differences in systolic function and ventricular wall thickness between hypertrophic cardiomyopathy patients with and without diastolic dysfunction.
  • Cardiac MRI offers detailed insights into HCM, including hypertrophy, function, obstruction, and fibrosis, aiding in patient management.

Impact:

  • Provides a comparative analysis of key cardiac parameters in HCM patients with varying diastolic function.
  • Emphasizes the utility of cardiac MRI in the detailed assessment and management of hypertrophic cardiomyopathy.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...